Startup spun out of SLU raises $30M in Series A funding
January 28, 2020 at 15:39 PM EST
The preclinical-stage biopharmaceutical startup, BioIntervene, was spun out of research from by SLU professor Daniela Salvemini.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|